OPINION: Ramifications Of The TPP Trade Deal On The Pharma Industry
This article was originally published in SRA
Executive Summary
The final text of the Trans-Pacific Partnership confirms beyond doubt the apprehensions expressed by civil society, academia and the generic industry about new barriers to access to medicines, says D G Shah.